A lithium dose of 600 mg three times daily (1800 mg/day total) is excessive for most patients and should be reduced to minimize toxicity risk while maintaining therapeutic efficacy.
The FDA-approved dosing for acute mania is 600 mg three times daily, but this represents a starting point that requires individualization based on serum levels and clinical response, not a fixed regimen. 1 More importantly, modern evidence strongly supports using lower doses than historically prescribed.
Key Dosing Principles
Target serum lithium levels of 0.6-0.8 mEq/L (or even 0.4-0.6 mEq/L in elderly patients) rather than the traditional 1.0-1.5 mEq/L range. 2 The evidence demonstrates that:
- Blood levels of 0.2-0.6 mEq/L are generally adequate for maintenance and typically achieved with 150-300 mg/day in elderly patients 2
- Lower plasma levels (0.45-0.79 mmol/L) result in significantly decreased affective morbidity and fewer side effects compared to conventional higher dosing 3
- Levels of 0.82-1.00 mmol/L are associated with increased side effects or early toxicity signs 4
Recommended Dosing Strategy
For acute mania: Start with 600 mg three times daily as per FDA labeling, but rapidly adjust based on serum levels drawn 8-12 hours after the previous dose 1. Monitor levels twice weekly during acute phase until stabilized.
For maintenance therapy: Reduce to 300 mg three or four times daily (900-1200 mg/day total), targeting serum levels of 0.6-1.2 mEq/L 1. However, recent evidence suggests even lower maintenance doses (achieving levels of 0.4-0.6 mEq/L) may be more effective with fewer side effects 3, 5.
For elderly patients: Elderly patients often respond to reduced dosages and may exhibit toxicity at levels ordinarily tolerated by younger patients 1. Target levels should be 0.4-0.6 mmol/L, typically achieved with 150-300 mg/day 2, 4.
Critical Monitoring Requirements
- Baseline: Complete blood count, thyroid function tests, urinalysis, BUN, creatinine, serum calcium, and pregnancy test in females 6
- Acute phase: Serum lithium levels twice weekly until stable 1
- Maintenance: Lithium levels, renal and thyroid function every 3-6 months 6
- Elderly patients: Monitor every 8-10 weeks 7
Important Caveats
Avoid lithium or use extreme caution with:
- GFR <30 ml/min/1.73 m² (requires nephrology consultation) 7
- Concurrent use of NSAIDs, diuretics, ACE inhibitors (increase toxicity risk) 8, 4, 9
- Significant cardiovascular disease, severe dehydration, or sodium depletion 1
Single daily dosing (preferably evening) may improve compliance and reduce polyuria without compromising efficacy, though peak levels will be transiently higher 10. This can be considered once stable dosing is achieved.
The 1800 mg/day dose you're questioning likely produces serum levels well above the optimal therapeutic range for most patients, increasing the risk of neurotoxicity, renal impairment, and thyroid dysfunction without additional therapeutic benefit. Dose reduction guided by serum levels is strongly recommended.